Remove 2023 Remove Generic Medicine Remove Packaging
article thumbnail

Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade

Pharmaceutical Technology

Go deeper with GlobalData Reports Future of Pharma - Looking Ahead to 2023 Reports China Contract Manufacturing Market Outlook - Trends, Ambitions, Ke. If successful, India will become the first country to sign a bilateral trade agreement (BTA) of such with the US during President Trump’s second term in the White House.

article thumbnail

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

This is due to the regulatory requirements imposed on parallel imported medicinal products in various Member States, the fulfilment of which often requires repackaging. Repackaging a medicinal product… means that the trademark is reapplied by an entity other than the trademark proprietor.”

article thumbnail

STAT+: ‘Like playing the lottery’: A mixed picture for laid-off life sciences workers in Massachusetts

STAT

At least 56 drug firms based in Massachusetts (or with operations here) have made layoffs or closed in 2023 through September, according to Dan Gold, president of Fairway Consulting Group, a life sciences recruiting firm. But the   drumbeat of layoffs in 2022   has only grown louder this year. He estimated U.S. Absolutely.”